Focus:
AI
-
16 July 2019
Recursion secures funds to support AI-based drug discovery
Artificial intelligence (AI) drug discovery firm Recursion Pharmaceuticals, has secured $121m in a series C funding round led by the Scottish Mortgage Investment Trust.
-
12 June 2019
Exscientia and GT Apeiron form AI drug discovery alliance
Exscientia has entered a multi-target partnership with China-based GT Apeiron Therapeutics.
-
10 June 2019
Janssen partners with nference for AI-based drug development
Janssen Research & Development has collaborated with software solutions provider nference to leverage artificial intelligence (AI) and data sciences for the discovery and clinical development of drugs.
-
4 June 2019
Lilly and Atomwise partner to use AI for drug discovery
Eli Lilly has formed a multi-target alliance with start-up Atomwise to support preclinical drug discovery efforts.
-
21 May 2019
Schrödinger raises $110m to develop drug discovery platform
Schrödinger has raised $110m during a funding round to develop its computational platform, which combines physics-based molecular simulations and machine learning for the exploration of chemical space.
-
1 May 2019
AstraZeneca forms drug discovery alliance with BenevolentAI
AstraZeneca has partnered with artificial intelligence (AI) company BenevolentAI to develop treatments for chronic kidney disease and idiopathic pulmonary fibrosis.
-
30 April 2019
Janssen to use Iktos’ AI technology for drug discovery
Janssen Pharmaceutica has initiated a collaboration agreement to use Iktos’ artificial intelligence (AI) technology to accelerate small molecule drug discovery.
-
28 March 2019
How machine learning and IoT can help the world’s poorest people
Plummeting cost-to-compute is making machine learning and IoT applications more accessible than ever. Here's why that could benefit soceity's poorest.
-
27 March 2019
Blue Brain Project clarifies neurons’ structure and role in disease
Swiss Ecole Polytechnique Fédérale de Lausanne (EPFL)’s Blue Brain Project has used a mathematical algorithm to distinguish the shape and structures of pyramidal cells.
-
25 March 2019
How government policy has shaped China’s pharma phenomenon
After many decades of growth, China is now the second largest global pharmaceutical market. Since the Chinese state closely controls the country’s economy, it’s unsurprising that government reforms have been...
Close
Close
Close
Go Top
